Gout Complications and Related Conditions

W.D. Auer/Alamy
By Lindsey Konkel
Updated on October 7, 2022
Medically Reviewed by Samir Dalvi, MD

Gout, a profoundly painful form of arthritis, arises from an excess accumulation of uric acid within the body. Uric acid is a natural byproduct of metabolic processes, typically cleared by the kidneys, stemming from the breakdown of purines found in certain foods. When uric acid levels in the blood become excessively high, a condition known as hyperuricemia occurs. This elevation can lead to the formation of sharp, needle-like urate crystals that deposit in joints, triggering sudden, excruciating attacks of inflammation and pain. (1)

For some individuals, gout transcends isolated episodes, evolving into a chronic condition characterized by recurrent, severe flares occurring multiple times throughout the year. This persistent inflammation, often termed gouty arthritis, demands vigilant management to prevent its progression. If left unaddressed, chronic gout can precipitate a cascade of serious health complications, significantly impacting quality of life and potentially leading to irreversible damage. Understanding these potential outcomes is crucial for effective long-term disease management. (2)

The detrimental effects of unchecked gout and sustained hyperuricemia extend beyond joint pain, encompassing a range of severe conditions. These complications can manifest as profound joint damage, leading to permanent deformities that impede normal movement and functionality. Furthermore, patients may experience a significant loss of mobility or range of motion, coupled with localized bone loss in affected areas. A hallmark of advanced gout involves the formation of tophi, which are uric acid deposits that can occur throughout the body. Beyond musculoskeletal issues, gout also carries a heightened risk of developing kidney stones and progressing to chronic kidney disease, underscoring its systemic impact.

What Is Tophaceous Gout? What Are Tophi Deposits?

Tophaceous gout represents an advanced stage of the condition, typically developing in individuals who have experienced repeated gout flares or persistently high uric acid levels over several years. A defining characteristic of tophaceous gout is the formation of tophi — hard, chalky deposits of uric acid crystals that manifest as visible lumps beneath the skin. These distinct nodules are not only cosmetic concerns but also indicators of significant, untreated uric acid buildup. They frequently appear on or near the elbow, finger, or toe joints, and can also be observed on the outer rim of the ear, signaling systemic involvement.

These tophi are far more than superficial blemishes; they are destructive crystalline masses capable of eroding and damaging surrounding bone and cartilage. This destructive process can lead to irreversible joint damage and severe physical deformity, greatly impairing joint function and causing chronic pain. During acute gout attacks, tophi can swell considerably, causing discomfort and increased pressure. In some cases, these swollen deposits may even break through the skin, creating open wounds that are highly susceptible to bacterial infections, further complicating management and posing risks to overall health. (3)

While the development of tophi signifies advanced gout, it is important to note that not every individual diagnosed with gout will progress to this stage. The risk of developing tophaceous gout is influenced by various factors, with certain demographic and medical conditions conferring a higher predisposition. For instance, organ transplant recipients who are on specific immunosuppressive medications to prevent organ rejection face an elevated risk. Similarly, individuals unable to take standard uric-acid-lowering therapies due to kidney failure or drug allergies are also more vulnerable. Postmenopausal women, particularly those undergoing treatment with diuretics for conditions like high blood pressure, exhibit a higher propensity for tophi formation, as diuretics can elevate uric acid concentrations in the bloodstream. (4)

Treatment for Tophaceous Gout and Tophi

The primary strategy for managing tophaceous gout revolves around consistent, long-term therapeutic intervention with uric-acid-lowering medications. The overarching goal of this treatment regimen is to achieve and sustain a consistently low level of uric acid in the blood, ideally maintaining it at or below 6 milligrams per deciliter (mg/dl). Successfully reaching and holding this target not only significantly diminishes the likelihood of future gout flares but also actively promotes the dissolution and eventual disappearance of existing tophi. These medications are instrumental in reversing the crystalline deposits that characterize tophaceous gout, thereby mitigating joint damage and improving overall prognosis. (5, 6)

It is essential for patients to understand that uric-acid-lowering medications require a sustained commitment to treatment and do not produce immediate results. The process of reducing uric acid levels and dissolving established tophi is gradual, often requiring several months of consistent medication adherence before noticeable improvements occur. Patience and regular follow-up with healthcare providers are key to successful management. Common medications prescribed for gout to achieve these lower uric acid levels include probenecid (Benemid), which helps the kidneys excrete more uric acid; losartan (Cozaar), primarily a blood pressure medication that also has uric-acid-lowering effects; allopurinol (Zyloprim) and febuxostat (Uloric), which reduce uric acid production; and pegloticase (Krystexxa), an enzyme therapy for severe, refractory gout.

Beyond pharmaceutical interventions, a comprehensive approach to managing uric acid levels and preventing gout complications integrates crucial lifestyle modifications. Adopting healthy habits significantly complements medication therapy. This includes maintaining adequate hydration by drinking plenty of water, which aids kidney function in uric acid excretion. Regular physical activity and achieving or maintaining a healthy body weight are also vital, as obesity is a known risk factor for gout severity. Additionally, strict avoidance of dietary triggers—such as alcoholic beverages, sugar-sweetened drinks, red meats, organ meats, and certain types of seafood rich in purines—can play a substantial role in minimizing uric acid buildup and preventing recurrent gout attacks.

Treating Gout and Tophi With Surgery

While uric-acid-lowering medications are highly effective in reducing the size of tophi over time, some individuals may still consider surgical removal. The decision to undergo surgery for tophi can stem from various motivations, including cosmetic concerns, particularly when the deposits are unsightly or located in highly visible areas. Beyond aesthetics, surgical intervention becomes a more pressing consideration when tophi cause significant mechanical interference with joint function, leading to painful limitations in movement or difficulties with daily activities such as walking. (7)

Surgical removal is often recommended by physicians when tophi are directly impinging upon nerves, causing nerve damage characterized by pain, numbness, or weakness in the affected limb. Furthermore, advanced tophi can erode through the skin, creating chronic ulcers or open lesions that are prone to persistent infection. In such cases, surgical debridement or complete removal of the infected tophus is necessary to prevent systemic complications. The procedure for tophi removal is generally considered straightforward, involving a small incision over the deposit, careful extraction of the crystalline mass, and subsequent closure of the wound with sutures.

For patients experiencing severe and irreversible joint damage or extensive bone loss around the affected joint as a consequence of long-standing tophaceous gout, simple tophi removal may not suffice. In these more extreme circumstances, medical professionals may recommend more extensive reconstructive procedures, including joint replacement surgery. This involves replacing the damaged joint surfaces with prosthetic components, aiming to restore functionality, alleviate chronic pain, and significantly improve the patient's overall quality of life when conservative medical treatments have proven insufficient to address the structural integrity of the joint.

The Link Between Gout and Kidney Stones

The fundamental issue of excess uric acid in the blood can have profound implications beyond the joints, notably contributing to the formation of kidney stones. When uric acid concentrations are too high, or if the kidneys struggle to efficiently filter this waste product, uric acid crystals can precipitate and aggregate within the urinary tract. These spiky, urate crystals can eventually coalesce, forming solid masses known as kidney stones. Once formed, these stones can become lodged anywhere along the urinary tract, from the kidneys themselves to the ureters, bladder, or urethra.

The presence of kidney stones often manifests with excruciating pain, typically experienced in the side of the abdomen or the back, often radiating to the groin. This pain can be intermittent and intensely sharp as the body attempts to pass the stone through the narrow urinary pathways. While most small kidney stones eventually pass out of the body through urine, larger stones may require medical intervention. Notably, uric acid kidney stones are a significant concern for gout patients, occurring in approximately 15 percent of individuals living with the condition, underscoring the close metabolic link between the two pathologies. (4)

It is crucial to recognize that uric acid is naturally excreted by the kidneys. Some uric-acid-lowering medications, designed to manage gout, function by increasing the amount of uric acid eliminated through the kidneys. While beneficial for controlling systemic uric acid levels, this mechanism can, in some cases, paradoxically elevate the concentration of uric acid in the urine, thereby increasing the risk of uric acid kidney stone formation in susceptible individuals. Therefore, patients using uric-acid-lowering drugs who develop symptoms suggestive of kidney stones should promptly consult their doctor. A healthcare professional can then assess the situation, potentially adjust medication regimens, or recommend alternative treatments to mitigate stone recurrence and manage discomfort. (4)

The Link Between Gout and Chronic Kidney Disease

A significant and often bidirectional relationship exists between gout and chronic kidney disease (CKD). Chronic kidney disease is a progressive condition characterized by a gradual decline in kidney function over time. The kidneys are indispensable organs, playing a vital role in maintaining overall health by filtering waste products, such as uric acid, from the blood and converting them into urine for excretion from the body. Their efficient operation is critical for regulating fluid balance, electrolyte levels, and blood pressure, among other essential physiological processes. (8)

The intricate connection between gout and CKD means that individuals diagnosed with chronic kidney disease face a heightened risk of developing gout. Conversely, people who have gout are also at an increased risk of developing chronic kidney disease. This reciprocal relationship highlights the systemic impact of uric acid dysregulation. When kidney function is compromised, the kidneys are less efficient at removing uric acid from the bloodstream, leading to its accumulation. This elevated uric acid level in the blood, known as hyperuricemia, directly contributes to the onset and exacerbation of gout. (9)

One notable pathway through which gout can contribute to the progression or worsening of chronic kidney disease is through recurrent kidney stones. As previously discussed, the formation of uric acid kidney stones is a known complication of gout. Individuals who experience frequent episodes of kidney stones are observed to have a higher risk of developing chronic kidney disease over time, as repeated stone passage can lead to kidney damage and inflammation. Recognizing this critical link, the National Kidney Foundation strongly advises that all individuals diagnosed with gout undergo regular screening for chronic kidney disease. This proactive approach typically involves simple blood and urine samples to assess kidney health. (9)

Healthcare providers utilize specific diagnostic tests to determine if kidney damage is present and to monitor kidney function. A key indicator is the Glomerular Filtration Rate (GFR) test, which measures how effectively the kidneys are filtering waste products from the blood each minute. A reduced GFR can indicate declining kidney function. Additionally, an Albumin-to-Creatinine Ratio (ACR) test assesses for the presence of albumin, a type of protein, in the urine. Elevated albumin levels in urine suggest kidney damage, as healthy kidneys typically do not allow significant amounts of protein to pass through. Regular monitoring through these tests is vital for early detection and management of kidney complications in gout patients. (9)

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Sources

1. Gout. Centers for Disease Control and Prevention. July 27, 2020.
2. Gout. Mayo Clinic. March 6, 2021.
3. Sriranganathan MK, Vinik O, Pardo Pardo J, et al. Interventions for Tophi in Gout. Cochrane Database of Systematic Reviews. August 11, 2021.
4. Perez-Ruiz F. Patient Education: Gout (Beyond the Basics). UpToDate. December 13, 2021.
5. Gout. Arthritis Foundation.
6. Treatments for Gout. Arthritis Foundation. June 10, 2022.
7. Kasper IR, Juriga MD, Giurini JM, Shmerling RH. Treatment of Tophaceous Gout: When Medication Is Not Enough. Seminars in Arthritis and Rheumatism. June 2016.
8. How Your Kidneys Work. National Kidney Foundation.
9. Kidney Disease and Gout [PDF]. National Kidney Foundation. 2016.

Original article: https://www.everydayhealth.com/gout/complications-related-conditions/